Skip to content

Patients › Recovery

Mga Blood Thinner sa Paligid ng Operasyon

PDF

How anticoagulants and antiplatelets work, and why the timing of stopping each before surgery differs — platelet turnover, half-lives and clot risk.

Ilustrasyon ng isang blood clot — mga red cell na nakulong sa isang mesh ng mga fibrin thread sa paligid ng isang kumpol ng mga platelet.
Ang clot ay mga platelet na nagsama-sama at pinatibay ng isang mesh ng mga fibrin thread — ang proseso na idinisenyo upang pigilan ng mga blood thinner. Kieran Hirpara 4.0

Ang pahinang ito ay isinalin ng makina at hindi pa nasusuri ng isang doktor. Ang bersyong Ingles ang siyang opisyal.

Ang "Blood thinner" ay sumasaklaw sa dalawang pamilya ng gamot na gumagana sa magkaibang paraan, at para sa operasyon sa upper-limb, ang aming instruksyon ay nakadepende sa kung aling pamilya ang iyong iniinom. Ang mga gamot na antiplatelet tulad ng aspirin at clopidogrel ay ipinagpapatuloy. Ang mga anticoagulant tulad ng warfarin, Xarelto, Eliquis at Pradaxa ay itinitigil 48 oras bago ang iyong operasyon. Ang pag-alam kung alin ang iyong iniinom, at kung paano ito talaga gumagana, ay ginagawang hindi gaanong nakakalito ang dalawang instruksyong ito.

Una, paano ba talaga namumuo ang dugo?

Ilustrasyon ng isang blood clot: mga platelet at red cell na nakulong sa isang fibrin mesh.
Nabubuo ang namuong dugo (clot) kapag nagkukumpulan ang mga platelet sa pinsala at isang mesh ng mga fibrin thread ang humuhuli sa mga blood cell upang selyuhan ito. OpenStax, Anatomy & Physiology, CC BY 3.0

Upang maunawaan ang iba't ibang blood thinner, makatutulong na malaman kung paano karaniwang tinatatakdan ng iyong dugo ang isang leak, dahil ang bawat gamot ay pumaputol sa magkakaibang hakbang.

Kapag ang isang blood vessel ay naputol o napinsala, tinatampalan ito ng iyong katawan sa dalawang yugto:

  1. Tinatampalan ng mga platelet ang puwang: ang mga mabilis na first responder. Ang mga platelet ay maliliit na fragment ng cell na umiikot sa dugo nang walang ginagawa hanggang sa kailanganin sila. Sa sandaling makatagpo sila ng napinsalang dingding ng vessel, sila ay nagiging malagkit, nagtitipon-tipon sa pinsala at nagsasama-sama, na bumubuo ng isang malambot at pansamantalang plug sa loob ng ilang segundo hanggang minuto. Isipin ito bilang emergency patch ng katawan.

  2. Pinatitigas ng clotting cascade ang plug. Ang platelet plug na iyon ay marupok sa sarili nito. Upang patatagin ito, ang dugo ay nagsasagawa ng isang chain reaction na tinatawag na clotting cascade, isang serye ng mga protina na tinatawag na clotting factors (karamihan ay ginagawa ng atay, at ang ilan sa mga ito ay nangangailangan ng vitamin K) na nag-aactivate sa isa't isa nang sunod-sunod, gaya ng isang hanay ng mga domino. Natatapos ang cascade sa pamamagitan ng paggawa sa isang protina na tinatawag na fibrinogen tungo sa fibrin, isang mesh ng mga pinong hibla na humahabi sa platelet plug at ikinukunci ito upang maging isang matigas at matatag na clot.

Kaya ang isang tapos na clot ay sa katunayan ay mga platelet na pinagdidikit ng isang fibrin mesh. Kapag tinatakpan nito ang isang sugat, iyon mismo ang iyong gusto; ngunit ang parehong prosesong nangyayari nang hindi ginusto sa loob ng isang artery o vein ay nagdudulot ng heart attack, stroke o DVT. Iyon ang dahilan kung bakit nirereseta ang mga blood thinner upang maiwasan ito.

Narito ang susi sa lahat ng nasa ibaba: ang dalawang pamilya ng blood thinner ay bawat isa ay humaharang sa magkaibang yugto. Ang mga gamot na Antiplatelet ay pinahihina ang unang hakbang (ang mga platelet); ang mga gamot na anticoagulant ay pumuputol sa ikalawa (ang clotting- factor cascade). Ang iisang pagkakaibang iyon ay nagpapaliwanag din kung bakit ang timing bago ang operasyon ay napakaiba, dahil ang "pagbawi" sa isang platelet ay hindi katulad ng "pagbawi" sa isang clotting factor.

Mga gamot na antiplatelet

(aspirin, clopidogrel/Plavix, ticagrelor/Brilinta, prasugrel/Effient)

Pinipigilan ng mga ito ang maliliit na blood cell na tinatawag na platelets mula sa pagdidikit-dikit upang bumuo ng clot.

  • Ang Aspirin at clopidogrel (at prasugrel) ay gumagana nang irreversibly: kapag naabot ng gamot ang isang platelet, ang platelet na iyon ay naka-off na para sa natitirang buhay nito. Hindi ito maaaring ibalik ng iyong katawan. Ang tanging paraan upang bumalik sa normal na clotting ay ang paggawa ng mga bagong platelet, at ang mga platelet ay nabubuhay lamang ng humigit-kumulang 7–10 araw, kung saan halos 10% ang napapalitan araw-araw. Samakatuwid, ang maikling paghinto ay halos walang naidudulot, at ang paghinto na sapat ang haba upang magkaroon ng epekto ay mag-iiwan sa isang heart stent o stroke risk na walang proteksyon sa loob ng isang linggo. Iyon ang dahilan kung bakit hindi namin hinihiling na itigil ang mga ito: ang maliit na panganib ng pagdurugo ay natatabunan ng panganib ng clot.
  • Ang Ticagrelor ay reversible; binibitawan nito ang platelet sa halip na permanenteng i-disable ito, kaya mas mabilis itong nawawala kaysa sa mga irreversible.
  • Ipinagpapatuloy ang Aspirin at clopidogrel. Huwag itong itigil para sa iyong operasyon, at kasama rito ang mga combination tablet (DuoCover, DuoPlidogrel, Piax Plus Aspirin). Tinatanong namin kung umiinom ka ng mga ito upang malaman ng team at makapagplano base rito. Kung gusto naming itigil mo ang isang blood thinner, ang instruksyon ay nasa iyong surgery details email; kung ang iyong email ay walang ganitong instruksyon, ipagpatuloy ang pag-inom ng lahat gaya ng normal.

Mga Anticoagulant

Ang mga ito ay gumagana sa mas ibabang bahagi ng clotting chain, sa mga clotting factor sa dugo sa halip na sa mga platelet.

Warfarin (Coumadin, Marevan). Pinipigilan ng Warfarin ang iyong atay sa paggawa ng ilang clotting factor na nakadepende sa vitamin-K. Hindi nito inaalis ang mga factor na kasalukuyan nang dumadaloy; ang mga ito ay kailangang maubos at malinis nang natural, na tumatagal ng mga 5 araw. Ang aming instruksyon para sa warfarin ay itigil ito 48 oras bago, kaya sa araw na iyon ay mayroon pa itong ilang epekto. Inaasahan ito; kung gusto namin ng blood test (ang INR) bago ang iyong operasyon, aayusin namin ito at sasabihan ka.

Ang mga mas bagong tablet: DOACs (apixaban/Eliquis, rivaroxaban/Xarelto, dabigatran/Pradaxa, edoxaban). Bawat isa ay humaharang sa isang partikular na clotting factor, at mabilis itong nililinis ng katawan, na may half-life na humigit-kumulang 12 oras. Dahil mabilis silang nawawala, ang 48 oras ay sapat na panahon para sa malaking bahagi nila na malinis na. Sabihan kami kung mayroon kang problema sa bato, dahil mas matagal bago lumabas ang gamot sa katawan (lalo na ang dabigatran, na lumalabas nang madalas sa pamamagitan ng mga bato). Hindi nila kailangan ng INR monitoring.

Heparin / low-molecular-weight heparin (enoxaparin/Clexane) injections. Short-acting; ginagamit upang maiwasan ang mga clot. Dahil nawawala ang bisa nito sa loob ng ilang oras, kung ikaw ay gumagamit ng mga injection, bibigyan ka ng partikular na oras para sa iyong huling dose.

Bakit ganito ang timing — sa isang linya

Dalawang panuntunan, isa para sa bawat pamilya ng gamot.

Mga gamot na antiplatelet (aspirin, clopidogrel at ang mga combination tablets): ituloy ang pag-inom. Kaunti lang ang nakakamit ng maikling break at mapanganib ang mahabang break, kaya hindi namin hinihiling ang alinman sa mga ito.

Mga anticoagulant (warfarin, Xarelto, Eliquis, Pradaxa): huling dose 48 oras bago ang iyong operasyon. Sa praktika:

  • Operasyon sa Lunes: huling dose noong nakaraang Biyernes ng gabi, o Sabado ng umaga, depende kung kailan mo ito karaniwang iniinom.
  • Operasyon sa Biyernes: huling dose noong nakaraang Martes ng gabi, o Miyerkules ng umaga.

Ang email ng mga detalye ng iyong operasyon ay nagbibigay sa iyo ng araw at oras na itinakda para sa iyo.

Ang dapat mong gawin

  • Magdala ng eksaktong listahan ng lahat ng iyong iniinom sa iyong pre-operative assessment, kabilang ang aspirin at mga supplement tulad ng fish oil, na nakakaapekto rin sa pagdurugo.
  • Kung ikaw ay umiinom ng aspirin o clopidogrel, ituloy ang pag-inom ng mga ito, at siguraduhing alam namin.
  • Kung ikaw ay umiinom ng anticoagulant, sundin nang eksakto ang araw at oras ng huling dose na nasa iyong surgery details email, at ang mga instruksyon sa muling pag-inom na ibibigay sa iyo pagkatapos.
  • Huwag na huwag ititigil, sisimulan o babaguhin ang blood thinner nang mag-isa, at huwag ipagpalagay na ang iyong timing ay katulad ng sa isang kaibigan.
  • Sabihin sa bawat clinician na kasangkot na ikaw ay umiinom nito.

Pagkatapos ng iyong operasyon

Muling sisimulan ang mga blood thinner kapag humupa na ang panganib ng pagdurugo, kung minsan ay sa loob ng isang araw, at kung minsan ay mas matagal pagkatapos ng operasyong may mas mataas na panganib ng pagdurugo. Sasabihin sa iyo nang eksakto kung kailan. Ang namuong dugo (clot) na pinipigilan ng gamot ay hindi nawawala dahil lamang nagkaroon ka ng operasyon, kaya ang muling pagsisimula sa tamang oras ay kasinghalaga ng pagtigil nito.

Tawagan kami kung

  • Napagtanto mong nakainom ka ng dosis na sinabihan kang laktawan, o nakalaktawan ka ng dosis na sinabihan kang inumin
  • Mayroon kang hindi pangkaraniwan o malalang pasa o pagdurugo, dugo sa ihi o dumi, maitim at malagkit na dumi, o pagdurugong hindi tumitigil
  • Hindi ka sigurado kung ano ang gagawin sa iyong blood thinner bago ang iyong operasyon: laging magtanong kaysa manghula

Reviewed by Dr Kieran Hirpara · 9 September 2026.

Talk to your treating clinician for advice specific to you.

For an appointment with the CQ Hand + Upper Limb team, ask your GP about a referral or visit www.cqupperlimb.com.

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International

Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees

Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.